Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of 4–20 ng/ml

A. V. D'Amico; R. Whittington; I. Kaplan; C. Beard; M. R. Jiroutek; S. B. Malkowicz; A. Wein; C. N. Coleman

doi:10.1016/S0360-3016(96)00633-5

Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of 4–20 ng/ml

A. V. D'Amico
, R. Whittington
, I. Kaplan
, C. Beard
, M. R. Jiroutek
, S. B. Malkowicz
, A. Wein
, C. N. Coleman

Campbell University

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	International Jorunal of Radiation, Oncology, Biology, Physics
Volume	37
DOIs	https://doi.org/10.1016/S0360-3016(96)00633-5
State	Published - Mar 15 1997

Disciplines

Pharmacy and Pharmaceutical Sciences

Access to Document

10.1016/S0360-3016(96)00633-5License: Unspecified

https://doi.org/10.1016/S0360-3016(96)00633-5

Cite this

D'Amico, A. V., Whittington, R., Kaplan, I., Beard, C., Jiroutek, M. R., Malkowicz, S. B., Wein, A., & Coleman, C. N. (1997). Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of 4–20 ng/ml. International Jorunal of Radiation, Oncology, Biology, Physics, 37. https://doi.org/10.1016/S0360-3016(96)00633-5

Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of 4–20 ng/ml. / D'Amico, A. V.; Whittington, R.; Kaplan, I. et al.
In: International Jorunal of Radiation, Oncology, Biology, Physics, Vol. 37, 15.03.1997.

Research output: Contribution to journal › Article › peer-review

D'Amico, AV, Whittington, R, Kaplan, I, Beard, C, Jiroutek, MR, Malkowicz, SB, Wein, A & Coleman, CN 1997, 'Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of 4–20 ng/ml', International Jorunal of Radiation, Oncology, Biology, Physics, vol. 37. https://doi.org/10.1016/S0360-3016(96)00633-5

D'Amico AV, Whittington R, Kaplan I, Beard C, Jiroutek MR, Malkowicz SB et al. Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of 4–20 ng/ml. International Jorunal of Radiation, Oncology, Biology, Physics. 1997 Mar 15;37. doi: 10.1016/S0360-3016(96)00633-5

@article{b5ab3ebd5c33401d80f3b18007aad800,

title = "Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of 4–20 ng/ml",

author = "D'Amico, \{A. V.\} and R. Whittington and I. Kaplan and C. Beard and Jiroutek, \{M. R.\} and Malkowicz, \{S. B.\} and A. Wein and Coleman, \{C. N.\}",

year = "1997",

month = mar,

day = "15",

doi = "10.1016/S0360-3016(96)00633-5",

language = "American English",

volume = "37",

journal = "International Jorunal of Radiation, Oncology, Biology, Physics",

}

TY - JOUR

T1 - Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of 4–20 ng/ml

AU - D'Amico, A. V.

AU - Whittington, R.

AU - Kaplan, I.

AU - Beard, C.

AU - Jiroutek, M. R.

AU - Malkowicz, S. B.

AU - Wein, A.

AU - Coleman, C. N.

PY - 1997/3/15

Y1 - 1997/3/15

UR - https://cufind.campbell.edu/pharmacy/1702

UR - https://doi.org/10.1016/S0360-3016(96)00633-5

U2 - 10.1016/S0360-3016(96)00633-5

DO - 10.1016/S0360-3016(96)00633-5

M3 - Article

VL - 37

JO - International Jorunal of Radiation, Oncology, Biology, Physics

JF - International Jorunal of Radiation, Oncology, Biology, Physics

ER -

Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of 4–20 ng/ml

Disciplines

Access to Document

Other files and links

Cite this